A detailed history of Squarepoint Ops LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 24,597 shares of SLP stock, worth $844,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,597
Holding current value
$844,169
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.46 - $46.86 $749,224 - $1.15 Million
24,597 New
24,597 $787,000
Q1 2024

May 15, 2024

BUY
$37.48 - $44.74 $271,505 - $324,096
7,244 New
7,244 $298,000
Q1 2023

May 15, 2023

SELL
$34.96 - $43.94 $898,472 - $1.13 Million
-25,700 Reduced 59.82%
17,262 $758,000
Q4 2022

Feb 14, 2023

BUY
$36.55 - $51.15 $1.03 Million - $1.45 Million
28,291 Added 192.84%
42,962 $1.57 Million
Q3 2022

Nov 14, 2022

BUY
$47.75 - $66.88 $700,540 - $981,196
14,671 New
14,671 $712,000
Q2 2022

Aug 15, 2022

SELL
$40.55 - $51.76 $296,136 - $378,003
-7,303 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$36.56 - $50.98 $266,997 - $372,306
7,303 New
7,303 $372,000
Q4 2021

Feb 14, 2022

SELL
$37.1 - $57.45 $273,686 - $423,808
-7,377 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$38.45 - $55.66 $276,647 - $400,473
-7,195 Reduced 49.38%
7,377 $291,000
Q2 2021

Aug 16, 2021

BUY
$49.67 - $68.96 $465,209 - $645,879
9,366 Added 179.91%
14,572 $800,000
Q1 2021

May 17, 2021

SELL
$60.06 - $89.52 $47,387 - $70,631
-789 Reduced 13.16%
5,206 $329,000
Q4 2020

Feb 16, 2021

BUY
$53.26 - $77.18 $319,293 - $462,694
5,995 New
5,995 $431,000
Q1 2020

May 15, 2020

SELL
$26.79 - $38.99 $1.22 Million - $1.77 Million
-45,429 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$29.07 - $35.63 $652,330 - $799,537
22,440 Added 97.61%
45,429 $1.32 Million
Q3 2019

Nov 14, 2019

BUY
$28.19 - $41.75 $648,059 - $959,790
22,989 New
22,989 $798,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $697M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.